Role of immune cells in hypertension.


Journal

British journal of pharmacology
ISSN: 1476-5381
Titre abrégé: Br J Pharmacol
Pays: England
ID NLM: 7502536

Informations de publication

Date de publication:
06 2019
Historique:
received: 16 04 2018
revised: 22 05 2018
accepted: 18 06 2018
pubmed: 29 6 2018
medline: 1 8 2020
entrez: 29 6 2018
Statut: ppublish

Résumé

Inflammatory processes have been shown to play an important role in the mechanisms involved in the pathogenesis of hypertension. Innate and adaptive immune responses participate in BP elevation and end-organ damage. Here, we discuss recent studies focusing on novel inflammatory and immune mechanisms that play roles in BP elevation. Different subpopulations of cells involved in innate and adaptive immune responses, such as dendritic cells, monocytes/macrophages and NK cells, on the one hand, and B and T lymphocytes, on the other, contribute to the vascular and kidney injury in hypertension. Unconventional innate-like T cells such as γδ T cells also participate in hypertensive mechanisms by priming both innate and adaptive immune cells, contributing to trigger vascular inflammation and BP elevation. These cells exert their effects in part via production of various cytokines including pro-inflammatory IFN-γ and IL-17 and anti-inflammatory IL-10. The present review summarizes some of these immune mechanisms that participate in the pathophysiology of hypertension. LINKED ARTICLES: This article is part of a themed section on Immune Targets in Hypertension. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.12/issuetoc.

Identifiants

pubmed: 29952002
doi: 10.1111/bph.14427
pmc: PMC6534777
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1818-1828

Subventions

Organisme : CIHR First Pilot Foundation Grant
ID : 143348
Pays : International
Organisme : CIHR
ID : 123465
Pays : Canada
Organisme : CIHR
ID : 102606
Pays : Canada

Informations de copyright

© 2018 The British Pharmacological Society.

Références

Hypertension. 2012 Feb;59(2):324-30
pubmed: 22146512
Science. 2011 Oct 7;334(6052):98-101
pubmed: 21921156
Curr Hypertens Rep. 2014 Feb;16(2):413
pubmed: 24407446
Hypertension. 2018 Apr;71(4):709-718
pubmed: 29378857
Immunity. 2014 Nov 20;41(5):737-52
pubmed: 25517614
J Clin Invest. 2014 Oct;124(10):4642-56
pubmed: 25244096
Arterioscler Thromb Vasc Biol. 2014 Jun;34(6):1240-8
pubmed: 24743429
Acta Pathol Microbiol Scand C. 1980 Feb;88(1):1-5
pubmed: 7376880
Curr Opin Immunol. 2016 Feb;38:75-85
pubmed: 26707651
Am J Pathol. 2011 Jan;178(1):434-41
pubmed: 21224080
Br J Pharmacol. 2017 Dec;174 Suppl 1:S208-S224
pubmed: 29055032
Hypertension. 2010 Feb;55(2):500-7
pubmed: 20038749
Immunity. 2011 Aug 26;35(2):161-8
pubmed: 21867926
Nat Rev Immunol. 2008 Jul;8(7):523-32
pubmed: 18566595
Hypertension. 2015 Mar;65(3):569-76
pubmed: 25601932
Circ Res. 2018 Mar 30;122(7):970-983
pubmed: 29437833
Science. 2011 Jan 7;331(6013):44-9
pubmed: 21212348
Eur Heart J. 2014 May 14;35(19):1238-44
pubmed: 24685711
Circulation. 2011 Sep 20;124(12):1370-81
pubmed: 21875910
J Leukoc Biol. 2015 Feb;97(2):259-71
pubmed: 25502468
J Clin Invest. 2015 Mar 2;125(3):1189-202
pubmed: 25664851
J Exp Med. 2018 Jan 2;215(1):21-33
pubmed: 29247045
Am J Hypertens. 2015 Nov;28(11):1339-46
pubmed: 25824450
Cell Rep. 2017 Oct 24;21(4):1009-1020
pubmed: 29069584
Circ Res. 2016 Apr 15;118(8):1233-43
pubmed: 26988069
J Hypertens. 2016 Jan;34(1):97-108
pubmed: 26630215
Nat Rev Immunol. 2009 Mar;9(3):162-74
pubmed: 19197294
Curr Hypertens Rep. 2011 Dec;13(6):465-72
pubmed: 21842150
Front Physiol. 2018 Feb 20;9:113
pubmed: 29515456
Nucleic Acids Res. 2018 Jan 4;46(D1):D1091-D1106
pubmed: 29149325
Nat Rev Immunol. 2009 Aug;9(8):556-67
pubmed: 19575028
Nat Rev Immunol. 2002 Mar;2(3):151-61
pubmed: 11913066
Trends Immunol. 2013 Nov;34(11):556-63
pubmed: 23954143
Annu Rev Immunol. 2014;32:121-55
pubmed: 24387714
Br J Pharmacol. 2017 Dec;174 Suppl 1:S272-S359
pubmed: 29055034
Circ Res. 2015 Oct 23;117(10):858-69
pubmed: 26294657
Dis Markers. 2017;2017:7146290
pubmed: 28757677
Br J Pharmacol. 2017 Dec;174 Suppl 1:S130-S159
pubmed: 29055038
Lancet. 2012 Dec 15;380(9859):2224-60
pubmed: 23245609
Hypertension. 2013 Jul;62(1):126-33
pubmed: 23716586
Curr Hypertens Rep. 2016 Mar;18(3):21
pubmed: 26846785
Hypertension. 2011 Mar;57(3):469-76
pubmed: 21263125
Circ Res. 2015 Mar 13;116(6):1022-33
pubmed: 25767287
Circ Res. 2005 Sep 30;97(7):716-24
pubmed: 16109917
Circulation. 2017 May 30;135(22):2155-2162
pubmed: 28330983
Br J Pharmacol. 2019 Jun;176(12):1818-1828
pubmed: 29952002
Hypertension. 2000 Sep;36(3):360-3
pubmed: 10988265
Am J Physiol Heart Circ Physiol. 2012 Sep 1;303(5):H587-96
pubmed: 22730392
Am J Physiol Heart Circ Physiol. 2007 Apr;292(4):H1789-95
pubmed: 17142347
JACC Basic Transl Sci. 2016 Dec;1(7):606-616
pubmed: 28280792
J Exp Med. 2007 Oct 1;204(10):2449-60
pubmed: 17875676
Nat Rev Immunol. 2013 Feb;13(2):88-100
pubmed: 23348415
Semin Immunol. 2016 Apr;28(2):129-36
pubmed: 27025975
Circulation. 2009 Jun 9;119(22):2904-12
pubmed: 19470887
Pharmacol Res. 2017 May;119:404-411
pubmed: 28279813
Hypertension. 2016 Jul;68(1):123-32
pubmed: 27217403
Circ Res. 2015 Aug 28;117(6):547-57
pubmed: 26156232
Immunol Res. 2013 Dec;57(1-3):12-22
pubmed: 24203440
Arterioscler Thromb Vasc Biol. 2013 Jun;33(6):1313-9
pubmed: 23520167
Hypertension. 2015 Nov;66(5):1023-33
pubmed: 26351030
Br J Pharmacol. 2017 Dec;174 Suppl 1:S17-S129
pubmed: 29055040
Eur Heart J. 2018 May 21;39(20):1818-1831
pubmed: 29514257
Am J Physiol Regul Integr Comp Physiol. 2002 Jul;283(1):R7-28
pubmed: 12069927
Circ Res. 2004 May 14;94(9):1203-10
pubmed: 15059935
FASEB J. 2016 May;30(5):1987-99
pubmed: 26873938
Arterioscler Thromb Vasc Biol. 2015 Mar;35(3):598-606
pubmed: 25573852
Am J Pathol. 2016 Nov;186(11):2846-2856
pubmed: 27640148
Acta Pathol Microbiol Scand A. 1976 Nov;84(6):523-8
pubmed: 998251
Hypertension. 2008 Aug;52(2):256-63
pubmed: 18541733
Semin Nephrol. 2013 Nov;33(6):565-74
pubmed: 24161041
Hypertension. 2014 Aug;64(2):305-14
pubmed: 24866139
Nat Rev Nephrol. 2017 Nov;13(11):669-680
pubmed: 28970585
Nat Immunol. 2015 Nov;16(11):1114-23
pubmed: 26482978
Semin Immunopathol. 2018 Jan;40(1):37-48
pubmed: 28842749
Arterioscler Thromb Vasc Biol. 2005 Oct;25(10):2106-13
pubmed: 16100037
Clin Sci (Lond). 2014 Feb;126(4):267-74
pubmed: 24144355
Circulation. 2016 Nov 1;134(18):1353-1368
pubmed: 27678262
Am J Hypertens. 2017 Jan;30(1):51-60
pubmed: 27653031
Br J Pharmacol. 2017 Dec;174 Suppl 1:S225-S271
pubmed: 29055036
Hypertension. 2014 Mar;63(3):565-71
pubmed: 24366079
Nat Biotechnol. 2016 Oct;34(10):1066-1071
pubmed: 27617738
Physiol Rev. 2017 Jul 1;97(3):1127-1164
pubmed: 28566539
Hypertension. 2012 Dec;60(6):1430-6
pubmed: 23108651

Auteurs

Antoine Caillon (A)

Lady Davis Institute for Medical Research, Sir Mortimer B. Davis-Jewish General Hospital, McGill University, Montreal, QC, Canada.

Pierre Paradis (P)

Lady Davis Institute for Medical Research, Sir Mortimer B. Davis-Jewish General Hospital, McGill University, Montreal, QC, Canada.

Ernesto L Schiffrin (EL)

Lady Davis Institute for Medical Research, Sir Mortimer B. Davis-Jewish General Hospital, McGill University, Montreal, QC, Canada.
Department of Medicine, Sir Mortimer B. Davis-Jewish General Hospital, McGill University, Montreal, QC, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH